| For: | Peng C, Zhou RL, Shao GZ, Rui JA, Wang SB, Lin M, Zhang S, Gao ZF. Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma. World J Gastroenterol 2005; 11(18): 2704-2708 [PMID: 15884107 DOI: 10.3748/wjg.v11.i18.2704] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i18/2704.htm |
| Number | Citing Articles |
| 1 |
Li Zhou, Xiao-Dong He, Jie Chen, Quan-Cai Cui, Qiang Qu, Jing-An Rui, Yu-Pei Zhao. Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma. European Journal of Cancer 2007; 43(4) doi: 10.1016/j.ejca.2006.10.025
|
| 2 |
Shan Wang, Qing-Yun Zhang. Association of Lysosome associated protein transmembrane 4 beta gene polymorphism with the risk of pancreatic cancer. Chinese Journal of Cancer Research 2010; 22(4) doi: 10.1007/s11670-010-0291-5
|
| 3 |
Bing Wang, Shan Wang, Guowei Liang, Jianjun Xu, Rouli Zhou, Qingyun Zhang. Association of lysosomal protein transmembrane 4 beta gene polymorphism with pancreatic carcinoma susceptibility in the Chinese population. Tumor Biology 2017; 39(6) doi: 10.1177/1010428317705518
|
| 4 |
Luying Liu, Xuefang Xu, Lili Jing, Gengyin Zhou, Zhang Cao, Yanchun Han, Rouli Zhou, Dajun Deng. Lysosomal-Associated Protein Transmembrane 4 Beta-35 Overexpression Is a Novel Independent Prognostic Marker for Gastric Carcinoma. PLOS ONE 2015; 10(2) doi: 10.1371/journal.pone.0118026
|
| 5 |
Lu Wang, Yue Meng, Jian-Jun Xu, Qing-Yun Zhang. The Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by Regulating LAPTM4B Expression. Molecular Cancer Research 2018; 16(5) doi: 10.1158/1541-7786.MCR-17-0519
|
| 6 |
Meng Zhang, Jian-Jun Xu, Rou-Li Zhou, Qing-Yun Zhang, Klaus Roemer. cAMP Responsive Element Binding Protein-1 Is a Transcription Factor of Lysosomal-Associated Protein Transmembrane-4 beta in Human Breast Cancer Cells. PLoS ONE 2013; 8(2) doi: 10.1371/journal.pone.0057520
|
| 7 |
Hua Yang, Fuxia Xiong, Xuanhui Wei, Yu Yang, Michael A. McNutt, Rouli Zhou. Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo. Cancer Letters 2010; 294(2) doi: 10.1016/j.canlet.2010.02.006
|
| 8 |
Fanling Meng, Hongtao Song, Chang Luo, Mingzhu Yin, Ye Xu, Haixia Liu, Rouli Zhou, Ge Lou. Correlation of LAPTM4B polymorphisms with cervical carcinoma. Cancer 2011; 117(12) doi: 10.1002/cncr.25833
|
| 9 |
S. Wang, Q-Y Zhang, R-L Zhou. Relationship between LAPTM4B gene polymorphism and susceptibility of primary liver cancer. Annals of Oncology 2012; 23(7) doi: 10.1093/annonc/mdr538
|
| 10 |
Yue Kang, Mingzhu Yin, Wei Jiang, Haiyu Zhang, Bairong Xia, Yingwei Xue, Yuenan Huang. Overexpression of LAPTM4B-35 is associated with poor prognosis in colorectal carcinoma. The American Journal of Surgery 2012; 204(5) doi: 10.1016/j.amjsurg.2012.02.003
|
| 11 |
Fanling Meng, Chang Luo, Yuanlong Hu, Mingzhu Yin, Ming Lin, Ge Lou, Rouli Zhou. Overexpression of LAPTM4B-35 in Cervical Carcinoma. International Journal of Gynecological Pathology 2010; 29(6) doi: 10.1097/PGP.0b013e3181e0898e
|
| 12 |
Mingzhu Yin, Cong Li, Xia Li, Ge Lou, Bing Miao, Xiaodong Liu, Fanling Meng, Haiyu Zhang, Xiuwei Chen, Meng Sun, Qiu Ling, Rouli Zhou. Over‐expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer. Journal of Surgical Oncology 2011; 104(1) doi: 10.1002/jso.21912
|
| 13 |
G Zhang, Y Liang, Y Huang, Y Chen, R Zhou. Elevated Lysosome-Associated Protein Transmembrane-4β-35 is an Independent Prognostic Marker in Pancreatic Carcinoma. Journal of International Medical Research 2012; 40(4) doi: 10.1177/147323001204000406
|
| 14 |
Li Zhou, Xiao-Dong He, Jian-Chun Yu, Rou-Li Zhou, Yi Shan, Jing-An Rui. Overexpression of LAPTM4B-35 attenuates epirubucin-induced apoptosis of gallbladder carcinoma GBC-SD cells. Surgery 2011; 150(1) doi: 10.1016/j.surg.2010.12.010
|
| 15 |
L Li, X H Wei, Y P Pan, H C Li, H Yang, Q H He, Y Pang, Y Shan, F X Xiong, G Z Shao, R L Zhou. LAPTM4B: A novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling. Oncogene 2010; 29(43) doi: 10.1038/onc.2010.303
|
| 16 |
Fan-ling Meng, Ming-zhu Yin, Hong-tao Song, Hua Yang, Ge Lou, Rou-li Zhou. LAPTM4B-35 Overexpression Is an Independent Prognostic Marker in Endometrial Carcinoma. International Journal of Gynecological Cancer 2010; 20(5) doi: 10.1111/IGC.0b013e3181e02f90
|
| 17 |
Xiaojing Cheng, Zhixue Zheng, Zhaode Bu, Xiaojiang Wu, Lianhai Zhang, Xiaofang Xing, Xiaohong Wang, Ying Hu, Hong Du, Lin Li, Shen Li, Rouli Zhou, Xian-Zi Wen, Jia-Fu Ji, Ken-ichi Mukaisho. LAPTM4B-35, a Cancer-Related Gene, Is Associated with Poor Prognosis in TNM Stages I-III Gastric Cancer Patients. PLOS ONE 2015; 10(4) doi: 10.1371/journal.pone.0121559
|
| 18 |
Hui Zhou, Yuyao Yi, Wei He, Li Zheng, Yiguo Hu, Ting Niu. A comprehensive prognostic and immune analysis of LAPTM4B in pan-cancer and Philadelphia chromosome-positive acute lymphoblastic leukemia. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1522293
|
| 19 |
Li Li, Yi Shan, Hua Yang, Sha Zhang, Ming Lin, Ping Zhu, Xin‐Yu Chen, Jing Yi, Michael A. Mcnutt, Gen‐Ze Shao, Rou‐Li Zhou. Upregulation of LAPTM4B‐35 Promotes Malignant Transformation and Tumorigenesis in L02 Human Liver Cell Line. The Anatomical Record 2011; 294(7) doi: 10.1002/ar.21421
|
| 20 |
Y. Liu, Q.-Y. Zhang, N. Qian, R.-L. Zhou. Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer. Annals of Oncology 2007; 18(2) doi: 10.1093/annonc/mdl394
|
| 21 |
Li Zhou, Xiao-Dong He, Quan-Cai Cui, Wei-Xun Zhou, Qiang Qu, Rou-Li Zhou, Jing-An Rui, Jian-Chun Yu. Expression of LAPTM4B-35: A novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma. Cancer Letters 2008; 264(2) doi: 10.1016/j.canlet.2008.01.025
|
| 22 |
X.-J. Cheng, W. Xu, Q.-Y. Zhang, R.-L. Zhou. Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers. Annals of Oncology 2008; 19(3) doi: 10.1093/annonc/mdm469
|
| 23 |
Xiaojing Cheng, Xiuyun Tian, Xiaojiang Wu, Xiaofang Xing, Hong Du, Chunlian Zhou, Qingyun Zhang, Chunyi Hao, Xianzi Wen, Jiafu Ji, Yuan-Jia Chen. Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers. PLOS ONE 2016; 11(7) doi: 10.1371/journal.pone.0158715
|
| 24 |
Li Zhou, Xiao-Dong He, Jian-Chun Yu, Rou-Li Zhou, Hua Yang, Qiang Qu, Jing-An Rui. Overexpression of LAPTM4B promotes growth of gallbladder carcinoma cells in vitro. The American Journal of Surgery 2010; 199(4) doi: 10.1016/j.amjsurg.2009.03.031
|
| 25 |
Bing Wang, Jianjun Xu, Rouli Zhou, Qingyun Zhang. Association of LAPTM4B gene polymorphism with nasopharyngeal carcinoma susceptibility in a Chinese population. Medical Oncology 2013; 30(1) doi: 10.1007/s12032-013-0470-6
|
| 26 |
Cuiju Mo, Yu Lu, Yan Deng, Jian Wang, Li Xie, Taijie Li, Yu He, Qiliu Peng, Xue Qin, Shan Li. LAPTM4B polymorphism increases susceptibility to multiple cancers in Chinese populations: a meta-analysis. BMC Genetics 2014; 15(1) doi: 10.1186/1471-2156-15-48
|
| 27 |
Xinrong Liu, Fuxia Xiong, Xuanhui Wei, Hua Yang, Rouli Zhou. LAPTM4B‐35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells. Cancer Science 2009; 100(12) doi: 10.1111/j.1349-7006.2009.01346.x
|
| 28 |
Mingzhu Yin, Chun Lou, Wang Zhang, Fanling Meng, Haiyu Zhang, Xiaoming Ning, Rouli Zhou, Xinshu Dong, Ge Lou. LAPTM4B Overexpression is a Novel Independent Prognostic Marker for Metastatic Ovarian Tumors. International Journal of Gynecological Cancer 2012; 22(1) doi: 10.1097/IGC.0b013e318234f9ac
|
| 29 |
Hua Yang, Ming Lin, Fuxia Xiong, Yu Yang, Xiu Nie, Michael A. Mcnutt, Rouli Zhou. Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase expression predicts clinical outcome in hepatocellular carcinoma patients. Surgery Today 2011; 41(6) doi: 10.1007/s00595-010-4338-5
|
| 30 |
Yanyan Huang, Fang Hu, Rui Zhao, Guanxin Zhang, Hua Yang, Deqing Zhang. Tetraphenylethylene Conjugated with a Specific Peptide as a Fluorescence Turn‐On Bioprobe for the Highly Specific Detection and Tracing of Tumor Markers in Live Cancer Cells. Chemistry – A European Journal 2014; 20(1) doi: 10.1002/chem.201303679
|
| 31 |
Lu Wang, Yue Meng, Qing-Yun Zhang. LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5506-7
|
| 32 |
Y. Xu, Y. Liu, R. Zhou, F. Meng, Y. Gao, S. Yang, X. Li, M. Yang, G. Lou. LAPTM4B Polymorphisms is Associated with Ovarian Cancer Susceptibility and Its Prognosis. Japanese Journal of Clinical Oncology 2012; 42(5) doi: 10.1093/jjco/hys026
|
| 33 |
Jianping Liao, Jiahong Wang, Yu Xu, Yong Wu, Meifeng Wang, Qiudong Zhao, Xiaodan Tan, Yan Meng, Lixin Wei, Aimin Huang. LAPTM4B-YAP loop feedback amplification enhances the stemness of hepatocellular carcinoma. iScience 2023; 26(6) doi: 10.1016/j.isci.2023.106754
|
| 34 |
鹤 王, 浩 张, 铄 邵, 敏 马, 旻 徐, 德胜 朱. LAPTM4B作为诊断、预后及免疫治疗应答生物标志物的泛癌分析. 临床医药循证研究 2026; 2(2) doi: 10.65140/ebcm202602.22
|
| 35 |
Mingzhu Yin, Ye Xu, Ge Lou, Yan Hou, Fanling Meng, Haiyu Zhang, Cong Li, Rouli Zhou. LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis. International Journal of Cancer 2011; 129(3) doi: 10.1002/ijc.25689
|